Denmark became the first country in the European Union (EU) to authorize the antiviral treatment molnupiravir, from the US laboratory Merck, for patients at risk with symptoms of coronavirus.
The drug in pill form, marketed under the name Lagevrio, was approved in November by the EU regulator for emergency use and was later formally authorized for marketing.
Lagevrio has been approved since November in the United Kingdom and is in the approval process in the United States, but its results, lower than expected, led countries to wait.
“We recommend treatment with the pill because we believe that the benefits outweigh the harms for those patients who are most at risk of becoming seriously ill from COVID-19.”said the head of the National Health Agency (SST) Kirstine Moll Harboe in a statement.
Denmark lives a record wave of cases of COVID-19 and an outbreak of the new omicron variant, which is expected to be dominant in Copenhagen this week.
The daily number of new cases stood at 8,770 on Wednesday, the highest number ever recorded for a country of 5.8 million people.
RECOMMENDED VIDEO
.
Ricardo is a renowned author and journalist, known for his exceptional writing on top-news stories. He currently works as a writer at the 247 News Agency, where he is known for his ability to deliver breaking news and insightful analysis on the most pressing issues of the day.
